Tower Research Capital (TRC)’s Defiance Daily Target 2X Long RKLB ETF RKLX Stock Holding History

Tower Research Capital (TRC)’s Portfolio RKLX Stock Details RKLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-174	Closed	-$6.92K	–	5702
2025 Q4	$6.92K	Buy	+174	New	+$6.39K	﹤0.01%	4042

Other funds holding RKLX

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s RKLX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Defiance Daily Target 2X Long RKLB ETF (RKLX) in Q1 2026, closing a stake of 174 shares — an estimated $6.92K sold.

Tower Research Capital (TRC) first reported a position in RKLX in Q4 2025 and held it in 1 quarter. The position peaked at $6.92K in Q4 2025. 9 funds tracked by Wall St. Rank hold RKLX as of Q1 2026.

Tower Research Capital (TRC) reported no remaining Defiance Daily Target 2X Long RKLB ETF position as of Q1 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 174 Defiance Daily Target 2X Long RKLB ETF shares in Q1 2026, an estimated $6.92K.
Tower Research Capital (TRC) first reported a position in Defiance Daily Target 2X Long RKLB ETF in Q4 2025 and held it in 1 quarter.
Tower Research Capital (TRC)'s Defiance Daily Target 2X Long RKLB ETF position peaked at $6.92K in Q4 2025.
9 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long RKLB ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.